Phase 3 Study of OMS103HP for ACL Surgery

Omeros announced results from its Phase 3 study of OMS103HP for arthroscopic anterior cruciate ligament (ACL) reconstruction surgery. OMS103HP did not meet prespecified endpoints of functional recovery, range of motion, and pain reduction.

OMS103HP is designed for use during arthroscopic surgery to improve postoperative joint motion and function and reduce postoperative pain.  OMS103HP is a proprietary combination of ketoprofen, amytriptyline and oxymetazoline that is injected into standard arthroscopic irrigation solutions and perfused through the joint in low concentrations during surgery. 

For more information call (206) 676-5000 or visit www.omeros.com.